Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
23
Number of overlapping holdings
30.7%
% of CNCR's 75 holdings also in CANC
51.1%
% of CANC's 45 holdings also in CNCR
Overlap by Weight
Sector Drift (CNCR minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CNCR |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 1.5% | 3.1% | 1.5% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | 1.5% | 2.1% | 1.5% |
|
MERCK & CO. INC. | 1.5% | 5.6% | 1.5% |
|
EXELIXIS INC | 1.4% | 2.4% | 1.4% |
|
BLUEPRINT MEDICINES CORP. | 1.4% | 2.6% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to CANC
|
GERON CORP | 3.0% |
|
ACRIVON THERAPEUTICS, INC. | 2.6% |
|
ENLIVEN THERAPEUTICS, INC. | 2.1% |
|
JANUX THERAPEUTICS, INC. | 1.8% |
|
NUVATION BIO INC CLASS A | 1.7% |
|
2SEVENTY BIO, INC. | 1.6% |
|
IMMUNITYBIO INC | 1.5% |
|
LYELL IMMUNOPHARMA, INC. | 1.4% |
|
Y-MABS THERAPEUTICS, INC. | 1.4% |
 |
MORPHOSYS AG SPONSORED ADR | 1.4% |
CNCR Underweight Relative to CANC
|
REGENERON PHARMACEUTICALS | -4.3% |
|
MERCK & CO. INC. | -4.1% |
 |
DAIICHI SANKYO CO LTD | -4.0% |
 |
ASTRAZENECA PLC | -3.8% |
 |
NOVARTIS AG | -3.7% |
|
ILLUMINA INC | -3.5% |
|
EXACT SCIENCES CORP | -3.1% |
 |
ARGENX SE ADR | -2.9% |
|
GILEAD SCIENCES INC | -2.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.7% |